Abstract:Unlike the crude study conducted at the beginning of nanomedicine, researchers have devoted more efforts to developing nanosystems with elaborated structures and multifunctions owing to the fact that the tumor microenvironment is complicated. However, it is still a great challenge to prepare these nanoplatforms for drug delivery. In this study, multifunctional prodrug nanocarriers were fabricated by the modularized host-guest selfassembly between cholesterol and beta-cyclodextrin. The targeted ligand lactobionic acid (LBA), fluorescent probe fluoresceine isothiocyanate (FITC), and chemtherapeutic drug doxorubicin (DOX) were integrated into the multifunctional supramolecualr drug nanocarriers. The host-guest interaction between Chol-PEG and beta-CD-hydrazone- DOX was confirmed by 2D H-1 NOESY spectrum. The modularized functional building blocks could self-assemble into micelles with a diameter of 20 nm. The supramolecular nanocarriers showed pH-sensitive drug release behavior. The release of DOX can be greatly accelerated in acidic endo/lysosomal pH. The internalization of the supramolecular drug nanocarriers by HepG2 cells was studied by fluorescence microscopy and flow cytometry. The nanocarriers can be well taken up by cancer cells. Due to the targeting ability of LBA, the internalization of the nanocarriers can be greatly inhibited if the cells are pre-treated by free LBA. At the same time, the fluorescence of FITC can be clearly observed intracellularly, which can be used to track the sub-cellular location of the drug nanocarriers. Finally, the cytotoxicity of the drug nanocarriers was investigaed by MTT assay. With the HepG2 cells pre-treated with free LBA, the cytotoxicity of the drug nanocarriers was significantly reduced, most probably owing to the unsatisfactory cell uptake. The concentration-dependent cytotoxicity toward HepG2 cells was also observed. Therefore, the integration of target ligand and imaging ligand have endowed the nanocarriers with targeted theranostic property. More importantly, since the modularized host-guest self-assembly is dynamically tunable, the percentage of functional ligands could be easily optimized to achieve a better outcome. Such multifunctional prodrug nanocarriers fabricated by modularized host-guest self-assembly may have great potential in drug delivery.

A Small Molecule Nanodrug Consisting of Amphiphilic Targeting Ligand-Chemotherapy Drug Conjugate for Targeted Cancer Therapy.

Nanodelivery of a Self-Assembling Prodrug with Exceptionally High Drug Loading Potentiates Chemotherapy Efficacy.

Supramolecular nanoparticle carriers self-assembled from cyclodextrin- and adamantane-functionalized polyacrylates for tumor-targeted drug delivery.

A Ph‐responsive Nanoparticle Delivery System Containing Dihydralazine and Doxorubicin‐based Prodrug for Enhancing Antitumor Efficacy

pH/Redox/Lysozyme-Sensitive Hybrid Nanocarriers With Transformable Size for Multistage Drug Delivery

Hyaluronic acid-conjugated methotrexate and 5-fluorouracil for targeted drug delivery

The in-and-out parent: strategies for managing reentry stress.

Construction of Multifunctional Drug Nanocarriers by Modularized Host-Guest Self-assembly

A Drug-Self-gated and Tumor Microenvironment-Responsive Mesoporous Silica Vehicle: "Four-in-one" Versatile Nanomedicine for Targeted Multidrug-Resistant Cancer Therapy

The Improved Delivery to Breast Cancer Based on a Novel Nanocarrier Modified with High-Affinity Peptides Discovered by Phage Display.

A Self-Disguised Nanospy for Improving Drug Delivery Efficiency via Decreasing Drug Protonation

Lanthanide-integrated supramolecular polymeric nanoassembly with multiple regulation characteristics for multidrug-resistant cancer therapy

Open label gabapentin treatment for pain in multiple sclerosis

Targeted delivery and stimulus-responsive release of anticancer drugs for efficient chemotherapy

A Ph-Responsive Glycolipid-Like Nanocarrier for Optimising the Time-Dependent Distribution of Free Chemical Drugs in Focal Cells.

Enzyme- and Ph-Sensitive Branched Polymer-Doxorubicin Conjugate-Based Nanoscale Drug Delivery System for Cancer Therapy

A chitosan/mesoporous silica nanoparticle-based anticancer drug delivery system with a “tumor-triggered targeting” property

Dual-Targeted Nanocarrier Based on Cell Surface Receptor and Intracellular Mrna: an Effective Strategy for Cancer Cell Imaging and Therapy

[Dopaminergic receptors, multiple targets for neuroleptics].

A Functionalized Hollow Mesoporous Silica Nanoparticles-Based Controlled Dual-Drug Delivery System for Improved Tumor Cell Cytotoxicity

A pH-responsive biomimetic drug delivery nanosystem for targeted chemo-photothermal therapy of tumors